MA
NVNO

MYDA Advisors’s enVVeno Medical NVNO Stock Holding History

MYDA Advisors’s Portfolio NVNO Stock Details NVNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-69
Closed -$33K – 153
2019
Q4 		$33K Sell
69
-1
-1% -$518 0.01% 107
2019
Q3 		$53K Buy
+70
New +$60.9K 0.02% 106

Other funds holding NVNO

GIA
Gladstone Institutional Advisory Palm Beach Gardens, Florida $3.16B AUM 29.04% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

MYDA Advisors's NVNO Position: Q1 2020 in Review

MYDA Advisors sold out of enVVeno Medical (NVNO) in Q1 2020, closing a stake of 69 shares — an estimated $33K sold.

MYDA Advisors first reported a position in NVNO in Q3 2019 and held it in 2 quarters. The position peaked at $53K in Q3 2019. 4 funds tracked by Wall St. Rank hold NVNO as of Q1 2020.

  • MYDA Advisors reported no remaining enVVeno Medical position as of Q1 2020 after selling out during the quarter.
  • MYDA Advisors sold 69 enVVeno Medical shares in Q1 2020, an estimated $33K.
  • MYDA Advisors first reported a position in enVVeno Medical in Q3 2019 and held it in 2 quarters.
  • MYDA Advisors's enVVeno Medical position peaked at $53K in Q3 2019.
  • 4 funds tracked by Wall St. Rank held enVVeno Medical as of Q1 2020.

Based on MYDA Advisors's 13F filing for Q1 2020, filed 14 May 2020.